KeyBanc analyst Scott Schoenhaus has revised the price target for Health Catalyst (HCAT, Financial), decreasing it from $7 to $5. Despite this adjustment, the firm maintains an Overweight rating on the company's stock. As the first quarter earnings approach, KeyBanc expects legislative policies, healthcare system utilization, and broader economic factors such as a potential economic slowdown and rising inflation to be central themes in the healthcare IT (HCIT) sector.
The current valuation of the HCIT sector is seen as discounted compared to the broader healthcare industry. KeyBanc suggests investors should concentrate on companies that can consistently meet or exceed expectations over the next year. The firm particularly highlights a reduced risk from companies that are strategically positioned within stable healthcare markets, specifically those serving the payer sector and large pharmaceutical companies.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 9 analysts, the average target price for Health Catalyst Inc (HCAT, Financial) is $7.11 with a high estimate of $10.00 and a low estimate of $4.00. The average target implies an upside of 92.19% from the current price of $3.70. More detailed estimate data can be found on the Health Catalyst Inc (HCAT) Forecast page.
Based on the consensus recommendation from 13 brokerage firms, Health Catalyst Inc's (HCAT, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Health Catalyst Inc (HCAT, Financial) in one year is $10.62, suggesting a upside of 187.03% from the current price of $3.7. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Health Catalyst Inc (HCAT) Summary page.
